首页> 外文期刊>Acta Pharmacologica Sinica >Identification of probable genomic packaging signal sequence from SARS-CoV genome by bioinformatics analysis
【24h】

Identification of probable genomic packaging signal sequence from SARS-CoV genome by bioinformatics analysis

机译:通过生物信息学分析鉴定SARS-CoV基因组中可能的基因组包装信号序列

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To predict the probable genomic packaging signal of SARS-CoV by bioinformatics analysis. The derived packaging signal may be used to design antisense RNA and RNA interfere (RNAi) drugs treating SARS. METHODS: Based on the studies about the genomic packaging signals of MHV and BCoV, especially the information about primary and secondary structures, the putative genomic packaging signal of SARS_CoV were analyzed by using bioinformatic tools. Multi-alignment for the genomic sequences was performed among SARS-CoV, MHV, BCoV, PEDV and HCoV 229E. Secondary structures of RNA sequences were also predicted for the identification of the possible genomic packaging signals. Meanwhile, the N and M proteins of all five viruses were analyzed to study the evolutionary relationship with genomic packaging signals. RESULTS: The putative genomic packaging signal of SARS-CoV locates at the 3′ end of ORF1b near that of MHV and BCoV, where is the most variable region of this gene. The RNA secondary structure of SARS-CoV genomic packaging signal is very similar to that of MHV and BCoV. The same result was also obtained in studying the genomic packaging signals of PEDV and HCoV 229E. Further more, the genomic sequence multi-alignment indicated that the locations of packaging signals of SARS-CoV, PEDV, and HCoV overlaped each other. It seems that the mutation rate of packaging signal sequences is much higher than the N protein, while only subtle variations for the M protein. CONCLUSIONS: The probable genomic packaging signal of SARS-CoV is analogous to that of MHV and BCoV, with the corresponding secondary RNA structure locating at the similar region of ORF1b. The positions where genomic packaging signals exist have suffered rounds of mutations, which may influence the primary structures of the N and M proteins consequently.
机译:目的:通过生物信息学分析预测SARS-CoV可能的基因组包装信号。衍生的包装信号可用于设计反义RNA和RNA干扰(RNAi)治疗SARS的药物。方法:基于对MHV和BCoV基因组包装信号的研究,特别是关于一级和二级结构的信息,利用生物信息学工具分析了SARS_CoV的假定基因组包装信号。在SARS-CoV,MHV,BCoV,PEDV和HCoV 229E之间进行了基因组序列的多重比对。还预测了RNA序列的二级结构以鉴定可能的基因组包装信号。同时,分析了所有五种病毒的N和M蛋白,以研究与基因组包装信号的进化关系。结果:SARS-CoV的推定基因组包装信号位于ORF1b的3'端,靠近MHV和BCoV,是该基因最易变的区域。 SARS-CoV基因组包装信号的RNA二级结构与MHV和BCoV非常相似。在研究PEDV和HCoV 229E的基因组包装信号时也获得了相同的结果。此外,基因组序列多重比对表明SARS-CoV,PEDV和HCoV的包装信号的位置彼此重叠。似乎包装信号序列的突变率比N蛋白高得多,而M蛋白只有微妙的变异。结论:SARS-CoV可能的基因组包装信号类似于MHV和BCoV,相应的二级RNA结构位于ORF1b的相似区域。基因组包装信号存在的位置经历了几轮突变,因此可能影响N和M蛋白的一级结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号